Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

331.15
Delayed Data
As of Jul 31
 +2.28 / +0.69%
Today’s Change
201.91
Today|||52-Week Range
340.34
+28.65%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues4.6B5.9B8.7B13.1B
 
 
 
 
 
Cost of Goods Sold2.6B3.4B4.6B6.3B
 
 
 
 
 
Depreciation And Amortization447.9M578.6M1.0B2.8B
 
 
 
 
 
 
Operating ExpensesGross Income1.6B2.0B3.0B4.0B
 
 
 
 
 
General Expenses951.0M1.4B2.2B3.9B
 
 
 
 
 
Research And Development298.2M400.5M599.4M1.1B
 
 
 
 
 
Total Operating Expenses4.0B5.3B7.9B13.0B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income622.6M597.1M778.9M85.2M
 
 
 
 
 
Extraordinary Credit63.9M27.5M300.0K102.1M
 
 
 
 
 
Extraordinary Charge-162.0M-309.3M-1.2B-1.3B
 
 
 
 
 
Pre-Tax Equity Earnings-4.5M1.3M6.0M--
 
 
 
 
Interest Expense On Debt69.0M148.6M239.8M411.8M
 
 
 
 
 
Other Expenses2.9M74.6M6.3M-188.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income456.0M245.1M-638.4M-1.7B
 
 
 
 
 
Income Taxes-196.9M-146.8M-112.7M-81.9M
 
 
 
 
 
Minority Interest-1.8M-1.0M-700.0K-300.0K
 
 
 
 
 
Net Income260.9M97.3M-750.4M-1.6B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS124.5M125.8M142.3M219.7M
 
 
 
 
 
Shares To Calculate EPS Diluted126.5M128.4M142.3M219.7M
 
 
 
 
 
 
Earnings Per ShareEPS$2.06$0.76-$5.27-$7.42
 
 
 
 
 
EPS Diluted$2.06$0.76-$5.27-$7.42